title: [Determination of the possibilities of targeted therapy for gastric cancer].
abstract: The objective of the investigation whose results are given in the paper was to compare a few HER2 testing techniques (immunohistochemistry, fluorescence in situ hybridization, and silver in situ hybridization) for adenocarcinomas of the stomach and esophagogastric junction. Different antibody clones and in situ hybridization kits were comparatively analyzed. Recommendations for the use of different testing methods and for the interpretation of their results are given.
authors.forename: L É
authors.initials: LÉ
authors.lastname: Zavalishina
authors.forename: Iu Iu
authors.initials: IuIu
authors.lastname: Andreeva
authors.forename: G A
authors.initials: GA
authors.lastname: Frank
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000295:instrumentation / Q000379:methods; D017404:In Situ Hybridization, Fluorescence / Q000295:instrumentation / Q000379:methods; D008297:Male; D011933:Reagent Kits, Diagnostic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy
chemical_list: D011933:Reagent Kits, Diagnostic; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human